Home / drug / D-0025-2026 Class III Reported 2025-10-22
FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05. Recalled by STAQ Pharma, Inc.
Reason for Recall Labeling: Incorrect or Missing Lot and/or Exp Date
Advertisement
Was this product in your home? Find safe, vetted alternatives. We may earn a commission on qualifying purchases.
Browse Safer Alternatives
Recall Number D-0025-2026
Classification Class III
Status Ongoing
Category drug
Initiated 2025-10-09
Reported 2025-10-22
Distribution Nationwide in the U.S.
Code Info Lot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025. Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer .